- A Case of Paraplegia after Successful Treatment of Cyberknife for Hepatocellular Carcinoma
-
Geum Youb Noh, Chul Ju Han, Youn Joo Kim, Ki Young Yang, Su Cheol Park, Jin Kim, Yu Cheol Kim, Mi Sook Kim
-
Journal of the Korean Liver Cancer Study Group. 2011;11(2):165-171. Published online September 30, 2011
-
-
-
Abstract
PDF
- Radiation therapy (RT) is one of the managements for unresectable hepatocellular carcinoma (HCC). Traditionally, RT has
played only a limited role in HCC treatment because of its low efficacy and the low tolerance of the liver for this modality.
However, as the technology of RT grows rapidly in recent years, indication of RT for HCC has been extended remarkably.
Stereotactic body radiation therapy (SBRT) is a technique that allows precise delivery of a large ablative radiation dose to the
tumor while sparing normal surrounding tissue in 1 to 5 fractions. As RT becomes useful therapeutic strategy, the important
problem is that there could be serious complication after RT. Here we present a case of 54 years old male with advanced stage of
HCC, who underwent a serious neurologic complication of paraplegia following Cyberknife (CK) treatment. He had a huge HCC
in right lobe of the liver, and initially transarterial chemoembolization (TACE) was performed with an unsatisfactory response.
Therefore, CK was performed, and another TACE was done for a new lesion, which was followed by remarkable complete
remission of the tumor. However, paraplegia developed in both of his lower extremities a year after CK. Investigation has shown
radiation myelitis as the cause of paralysis. Three and a half years have passed since CK treatment, and HCC is still in complete
remission state, however, paraplegia is persistent now. Radiation myelitis should be considered as a complication, when CK is
applied to treatment of HCC.
- A Case of Hepatocellular Carcinoma Who had Surgical Resection Following TACE and Sorafenib Chemotherapy
-
Geum Youb Noh, Chul Ju Han, Youn Joo Kim, Ki Young Yang, Su Cheol Park, Jin Kim, Yu Cheol Kim, Yoon Hee Choi, Hyo Rak Lee
-
Journal of the Korean Liver Cancer Study Group. 2011;11(1):65-68. Published online February 28, 2011
-
-
-
Abstract
PDF
- Surgical resection for hepatocellular carcinoma (HCC) is one of the managements, showing improved long term survival.
Nowadays, it is being accepted as the main curative treatment. However, the biggest problem we used to face is that surgery
cannot be applied at the point of presentation in many patients due to advanced stage. Here we present a case of 54 years old
female, who had transarterial chemoembolization (TACE) and sorafenib due to advanced stage of HCC, and later underwent
curative surgery due to remarkable response. She had a CT scan of abdomen, which showed multiple huge masses. HCC was
confirmed by ultrasonography-guided liver biopsy. TACE was performed once. After TACE, the size of masses increased.
Therefore, sorafenib was administered and then continued for 9 months. As partial response was obtained at that time, surgical
resection was successfully done. In the pathological report of removed tumor, we could confirm total necrosis of tumor. Now, its
been 6 months and she is followed up without any recurrence.
|